A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
South Florida law firm Searcy Denney Scarola Barnhart & Shipley announced it has filed seven additional lawsuits against Stryker Orthopaedics, over the company’s Rejuvenate and ABG II hip implant systems. The Sacramento Bee